Literature DB >> 3084552

Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures.

C L Woodley.   

Abstract

Clinical isolates of Mycobacterium tuberculosis were used to compare various concentrations of streptomycin and ethambutol in the BACTEC 460 (Johnston Laboratories, Inc., Towson, Md.) radiometric method for drug susceptibility testing with those in the conventional method. Streptomycin used at 2.0 micrograms/ml for both methods showed a 0.99 agreement with susceptible strains and a 0.97 agreement with resistant strains. Ethambutol used at 2.5 micrograms/ml for the radiometric method showed 1.00 agreement with both susceptible and resistant strains when compared with ethambutol at 5.0 micrograms/ml for the conventional method.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084552      PMCID: PMC268651          DOI: 10.1128/jcm.23.2.385-386.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

2.  Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique.

Authors:  G Vincké; O Yegers; H Vanachter; P A Jenkins; J P Butzler
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

3.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

4.  Recovery and susceptibility testing of Mycobacterium tuberculosis from extrapulmonary specimens by the BACTEC radiometric method.

Authors:  G Fadda; S L Roe
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

5.  Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex.

Authors:  A Laszlo; P Gill; V Handzel; M M Hodgkin; D M Helbecque
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

6.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

8.  Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

Authors:  D E Snider; R C Good; J O Kilburn; L F Laskowski; R H Lusk; J J Marr; Z Reggiardo; G Middlebrook
Journal:  Am Rev Respir Dis       Date:  1981-04
  8 in total
  9 in total

1.  Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Authors:  B Madison; B Robinson-Dunn; I George; W Gross; H Lipman; B Metchock; A Sloutsky; G Washabaugh; G Mazurek; J Ridderhof
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP.

Authors:  L E Nilsson; S E Hoffner; S Anséhn
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Authors:  Linda M Parsons; Max Salfinger; Anne Clobridge; Jillian Dormandy; Lisa Mirabello; Valerie L Polletta; Ahmet Sanic; Oleg Sinyavskiy; Susan C Larsen; Jeffrey Driscoll; Genet Zickas; Harry W Taber
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Role of embB in natural and acquired resistance to ethambutol in mycobacteria.

Authors:  F Alcaide; G E Pfyffer; A Telenti
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method.

Authors:  H Tomioka; H Saito; K Fujii; K Sato; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

6.  Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium.

Authors:  C L Woodley; R W Smithwick
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

7.  A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  Yong-Gyun Jung; Hyejin Kim; Sangyeop Lee; Suyeoun Kim; EunJi Jo; Eun-Geun Kim; Jungil Choi; Hyun Jung Kim; Jungheon Yoo; Hye-Jeong Lee; Haeun Kim; Hyunju Jung; Sungweon Ryoo; Sunghoon Kwon
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

8.  Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.

Authors:  Halima M Said; Marleen M Kock; Nazir A Ismail; Kamaldeen Baba; Shaheed V Omar; Ayman G Osman; Anwar A Hoosen; Marthie M Ehlers
Journal:  BMC Infect Dis       Date:  2012-12-22       Impact factor: 3.090

9.  Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs.

Authors:  Sangyeop Lee; Daehyun Chu; Youn Mi Choi; EunJi Jo; Suyeoun Kim; Haeun Kim; Hyun Jung Kim; Jeonghyun Chang; Heungsup Sung; Geumrae Kang; Bonghwan Jin; Eun-Geun Kim; Sunghoon Kwon; Mi-Na Kim
Journal:  Front Microbiol       Date:  2019-04-16       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.